Atlas Trials

Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia

Clinical trial NCT01374373 · COMPLETED

Trial details

NCT number
NCT01374373
Sponsor
Bio Sidus SA
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Antineoplastic Chemotherapy Induced Anemia
Start date
2011-06-01
Primary completion
2014-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.